Article
Sorcin-STAT3-Serpin E1/CCL5 axis can be the trigger of pancreatic cancer-associated…
medRxiv · 2023 · Gong, J.; Wei, X.; Feng, Z.; Lou, J.; Sun, Y.; Hu, S.; Wu, J.; Wu, Y.
Key facts
| Title | Sorcin-STAT3-Serpin E1/CCL5 axis can be the trigger of pancreatic cancer-associated new-onset diabetes |
|---|---|
| First author | Gong, J.; Wei, X.; Feng, Z.; Lou, J.; Sun, Y.; Hu, S.; Wu, J.; Wu, Y. |
| Journal | medRxiv |
| Published | Jul 22, 2023 |
| DOI | 10.1101/2023.07.20.549805 |
| Devices mentioned | K852441, K854177, K854178, K854179, K854180, K854181, K854182, K854183, K854184, K854185, K854186, K854187 and 1 more |
| Product codes mentioned | CDT, CEO, CGA, CGX, CHH, CIG, CIS, CIX, CJE, CKA, KLB, KLS and 3 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1